serum antibodies surrogate markers p53 alterations preclinical cancer ancillary prospective trial abate progressive development clinical stages chronic obstructive pulmonary disease conducted retrospective nested study cases diagnosed cancer trial enzyme immunoassay immunoblotting immunoprecipitation used detect serum immunohistochemistry ihc detect p53 accumulation conformation polymorphism dna sequencing detect p53 mutations tumor samples detected types assays NUMBER cancer patients NUMBER detectable diagnosis NUMBER lung cancers NUMBER NUMBER months NUMBER prostate cancer NUMBER months NUMBER breast cancer NUMBER months patients tumors NUMBER patients NUMBER NUMBER p53 missense mutations base pair deletion tumors NUMBER noncancer copd controls matched cancer cases age gender smoking habits negative results indicate facilitate early diagnosis cancer subset smokers chronic obstructive pulmonary disease increased cancer risk anti p53 p53 abs case control p53 abs single strand p53 abs p53 abs ab positive ihc positive ab positive ab negative ihc positive p53 abs p53 abs